Can
  
Ficicioglu
MD,PhD
Email: 
Ficicioglu@email.chop.edu
Address: 
Division of Metabolism(Biochemical Genetics) The Children's Hospital of Philadelphia 3501 Civic center blvd #9054.
215 590 3376
Affiliations
Expertise

Dr. Ficicioglu is developing algorithms for the effective short and long-term care of patients detected by newborn screening, and new drugs to treat lysosomal storage disorders.

Appointments
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia (2011– present)
Assistant Professor of Pediatrics at the Children's Hospital of Philadelphia (2002 – 2011)
Education
PhD, Histology & Embryology, University of Marmara (1996)
MD, University of Istanbul, Cerrahpasa Medical School ( with High Honors) (1985)
Selected Publications
Chadwick S, Fitzgerald K, Weiss B, Ficicioglu C. Thirteen patients with MAT1A mutations detected through newborn screening: 13 years experience. JIMD report. 2014.
Coughlin CR, Hyland K,Randall R,Ficicioglu C. Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: A case report.. JIMD reports. 2013.
Ficicioglu C, Dubroff JG, Thomas N , Gallagher PR, Burfield J, Hussa C. Randall R. Zhuang H. A pilot study of fluorodeoxyglucose positron emission tomography findings in patients with phenylketonuria before and during sapropterin supplementation. Journal of Clinical Neurology. 2013.
Hazard FK, Ficicioglu CH, Ganesh J, Ruchelli ED.. Liver pathology in infantile mitochondrial DNA depletion syndrome. Pediatr Dev Pathol. 2013.
Grünert SC, Stucki M, Morscher RJ, Suormala T, Bürer C, Burda P, Christensen E, Ficicioglu C, Herwig J, Kölker S, Möslinger D, Pasquini E, Santer R, Schwab KO, Wilcken B, Fowler B, Yue WW, Baumgartner MR.. 3-Methylcrotonyl-CoA Carboxylase Deficiency: Clinical, biochemical, enzymatic and molecular studies in 88 individuals.. Orphanet J Rare Dis.. Vol 7(1). 2012 May:31.
Kim SZ, Song WJ, Nyhan WL, Ficicioglu C, Mandell R, Shih VE.. Long-term follow-up of four patients affected by HHH syndrome.. Clin Chim Acta.. 2012 March.
Badik JR, Castañeda U, Gleason TJ, Spencer JB, Epstein MP, Ficicioglu C, Fitzgerald K, Fridovich-Keil JL.. Ovarian function in Duarte galactosemia.. Fertil Steril.. Vol 96(2). 2011 August.
Fukao T, Sass JO, Kursula P, Thimm E, Wendel U, Ficicioglu C, Monastiri K, Guffon N, Baric I, Zabot MT, Kondo N.. Clinical and molecular characterization of five patients with succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency.. Biochim Biophys Acta.. Vol 1812(5). 2011 May.
Ficicioglu C, Hussa C, Gallagher PR, Thomas NH, Yager C.. Monitoring of Biochemical Status in Children with Duarte Galactosemia: Utility of Galactose, Galactitol, Galactonate and Galactose-1-Phosphate.. Clinical Chemistry. 2010 May.